Haemophilia is a rare disease affecting about 6000 people in the UK. Recently, many new treatments for haemophilia have been developed resulting in the need for many competing studies to be performed in the UK simultaneously. Delivery of these studies, on time and to target, has been successfully coordinated by the NIHR Clinical Research Network